Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui China Resources Jinchan Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of China Resources Sanjiu Medical & Pharmaceutical. The company is best known for its flagship oncology product, Huachansu (Cinobufacini), which is a therapeutic agent derived from the venom of the giant toad (Bufo gargarizans). Jinchan Pharmaceutical operates as a high-tech enterprise that integrates the research, development, and large-scale production of modern Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. Its manufacturing facilities in Anhui province are GMP-certified and specialize in sterile injections and extraction technologies. The company's portfolio primarily addresses critical needs in oncology, respiratory health, and anti-infective medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui China Resources Jinchan Pharmaceutical.